ReP USP - Resultado da busca

Artigo de periodico
Enhanced immunogenicity and protective effects against SARS-CoV-2 following immunization with a recombinant RBD-IgG chimeric protein (2024)
Silva, Mariângela de Oliveira ; Castro-Amarante, Maria Fernanda ; Carvalho, Alexia Adrianne Venceslau Brito ; Almeida, Bianca da Silva; Daher, Isabela Pazotti ; Souza-Silva, Guilherme Antonio de ; Yamamoto, Marcio Massao ; Koike, Gabriela ; Souza, Edmarcia Elisa de ; Wrenger, Carsten ; Ferreira, Luis Carlos de Souza ; Boscardin, Silvia Beatriz
Fonte: Vaccines. Unidades: ICB, FM
Assuntos: PARASITOLOGIA, MICROBIOLOGIA, PROTEÍNAS RECOMBINANTES, PROTEÍNAS SANGUÍNEAS, ANTICORPOS, IMUNOGENICIDADE DA VACINA, IMUNOGENÉTICA, IMUNOGLOBULINAS, COVID-19, VACINAS VIRAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Mariângela de Oliveira et al. Enhanced immunogenicity and protective effects against SARS-CoV-2 following immunization with a recombinant RBD-IgG chimeric protein. Vaccines, v. 12, n. 4, p. 14 , 2024Tradução . . Disponível em: https://doi.org/10.3390/vaccines12040356. Acesso em: 19 nov. 2024.
APA
Silva, M. de O., Castro-Amarante, M. F., Carvalho, A. A. V. B., Almeida, B. da S., Daher, I. P., Souza-Silva, G. A. de, et al. (2024). Enhanced immunogenicity and protective effects against SARS-CoV-2 following immunization with a recombinant RBD-IgG chimeric protein. Vaccines, 12( 4), 14 . doi:10.3390/vaccines12040356
NLM
Silva M de O, Castro-Amarante MF, Carvalho AAVB, Almeida B da S, Daher IP, Souza-Silva GA de, Yamamoto MM, Koike G, Souza EE de, Wrenger C, Ferreira LC de S, Boscardin SB. Enhanced immunogenicity and protective effects against SARS-CoV-2 following immunization with a recombinant RBD-IgG chimeric protein [Internet]. Vaccines. 2024 ; 12( 4): 14 .[citado 2024 nov. 19 ] Available from: https://doi.org/10.3390/vaccines12040356
Vancouver
Silva M de O, Castro-Amarante MF, Carvalho AAVB, Almeida B da S, Daher IP, Souza-Silva GA de, Yamamoto MM, Koike G, Souza EE de, Wrenger C, Ferreira LC de S, Boscardin SB. Enhanced immunogenicity and protective effects against SARS-CoV-2 following immunization with a recombinant RBD-IgG chimeric protein [Internet]. Vaccines. 2024 ; 12( 4): 14 .[citado 2024 nov. 19 ] Available from: https://doi.org/10.3390/vaccines12040356
Artigo de periodico
Anti-RBD IgG antibodies from endemic coronaviruses do not protect against the acquisition of SARS-CoV-2 infection among exposed uninfected individuals (2024)
Adami, Flávia Lopes ; Castro, Mateus Vidigal de ; Almeida, Bianca da Silva ; Daher, Isabela Pazotti ; Yamamoto, Marcio Massao ; Santos, Keity Souza ; Zatz, Mayana ; Naslavsky, Michel Satya ; Rosa, Daniela Santoro ; Cunha Neto, Edecio ; Oliveira, Vivian Leite de ; Kalil Filho, Jorge Elias ; Boscardin, Silvia Beatriz
Fonte: Frontiers in Immunology. Unidades: ICB, FM, IB
Assuntos: PARASITOLOGIA, ANTIVIRAIS, COVID-19, CORONAVIRUS, INFECÇÕES POR CORONAVIRUS, IMUNOGLOBULINAS, GLICOPROTEÍNAS, ESTUDOS DE COORTES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ADAMI, Flávia Lopes et al. Anti-RBD IgG antibodies from endemic coronaviruses do not protect against the acquisition of SARS-CoV-2 infection among exposed uninfected individuals. Frontiers in Immunology, v. 15, p. 10 , 2024Tradução . . Disponível em: https://doi.org/10.3389/fimmu.2024.1396603. Acesso em: 19 nov. 2024.
APA
Adami, F. L., Castro, M. V. de, Almeida, B. da S., Daher, I. P., Yamamoto, M. M., Santos, K. S., et al. (2024). Anti-RBD IgG antibodies from endemic coronaviruses do not protect against the acquisition of SARS-CoV-2 infection among exposed uninfected individuals. Frontiers in Immunology, 15, 10 . doi:10.3389/fimmu.2024.1396603
NLM
Adami FL, Castro MV de, Almeida B da S, Daher IP, Yamamoto MM, Santos KS, Zatz M, Naslavsky MS, Rosa DS, Cunha Neto E, Oliveira VL de, Kalil Filho JE, Boscardin SB. Anti-RBD IgG antibodies from endemic coronaviruses do not protect against the acquisition of SARS-CoV-2 infection among exposed uninfected individuals [Internet]. Frontiers in Immunology. 2024 ; 15 10 .[citado 2024 nov. 19 ] Available from: https://doi.org/10.3389/fimmu.2024.1396603
Vancouver
Adami FL, Castro MV de, Almeida B da S, Daher IP, Yamamoto MM, Santos KS, Zatz M, Naslavsky MS, Rosa DS, Cunha Neto E, Oliveira VL de, Kalil Filho JE, Boscardin SB. Anti-RBD IgG antibodies from endemic coronaviruses do not protect against the acquisition of SARS-CoV-2 infection among exposed uninfected individuals [Internet]. Frontiers in Immunology. 2024 ; 15 10 .[citado 2024 nov. 19 ] Available from: https://doi.org/10.3389/fimmu.2024.1396603
Artigo de periodico
Diagnostic and vaccine potential of Zika virus envelope protein (E) derivates produced in bacterial and insect cells (2023)
Lunardelli, Victória Alves Santos ; Almeida, Bianca da Silva ; Apostolico, Juliana de Souza ; Rezende, Thais; Yamamoto, Marcio Massao ; Pereira, Samuel Santos ; Bueno, Maria Fernanda Campagnari ; Pereira, Lennon Ramos ; Karina Inacio Carvalho ; Slhessarenko, Renata Dezengrini ; Rosa, Daniela Santoro ; Ferreira, Luís Carlos de Souza ; Boscardin, Silvia Beatriz
Fonte: Frontiers in Immunology. Unidade: ICB
Assuntos: MICROBIOLOGIA, PARASITOLOGIA, ZIKA VÍRUS, ZIKA VÍRUS, CAMUNDONGOS ENDOGÂMICOS C57BL, DROSOPHILA, VACINAS VIRAIS, INFECÇÕES POR VÍRUS DE RNA, PROTEÍNAS RECOMBINANTES, GLICOPROTEÍNAS, CÁPSULAS, ANTICORPOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LUNARDELLI, Victória Alves Santos et al. Diagnostic and vaccine potential of Zika virus envelope protein (E) derivates produced in bacterial and insect cells. Frontiers in Immunology, v. 14, p. 1-14, 2023Tradução . . Disponível em: https://doi.org/10.3389/fimmu.2023.1071041. Acesso em: 19 nov. 2024.
APA
Lunardelli, V. A. S., Almeida, B. da S., Apostolico, J. de S., Rezende, T., Yamamoto, M. M., Pereira, S. S., et al. (2023). Diagnostic and vaccine potential of Zika virus envelope protein (E) derivates produced in bacterial and insect cells. Frontiers in Immunology, 14, 1-14. doi:10.3389/fimmu.2023.1071041
NLM
Lunardelli VAS, Almeida B da S, Apostolico J de S, Rezende T, Yamamoto MM, Pereira SS, Bueno MFC, Pereira LR, Karina Inacio Carvalho, Slhessarenko RD, Rosa DS, Ferreira LC de S, Boscardin SB. Diagnostic and vaccine potential of Zika virus envelope protein (E) derivates produced in bacterial and insect cells [Internet]. Frontiers in Immunology. 2023 ; 14 1-14.[citado 2024 nov. 19 ] Available from: https://doi.org/10.3389/fimmu.2023.1071041
Vancouver
Lunardelli VAS, Almeida B da S, Apostolico J de S, Rezende T, Yamamoto MM, Pereira SS, Bueno MFC, Pereira LR, Karina Inacio Carvalho, Slhessarenko RD, Rosa DS, Ferreira LC de S, Boscardin SB. Diagnostic and vaccine potential of Zika virus envelope protein (E) derivates produced in bacterial and insect cells [Internet]. Frontiers in Immunology. 2023 ; 14 1-14.[citado 2024 nov. 19 ] Available from: https://doi.org/10.3389/fimmu.2023.1071041
Artigo de periodico
Dendritic cell targeting using a DNA vaccine induces specific antibodies and CD4+ T cells to the dengue virus envelope protein Domain III (2019)
Zaneti, Arthur Baruel; Yamamoto, Marcio Massao ; Sulczewski, Fernando Bandeira; Almeida, Bianca da Silva; Souza, Higo Fernando Santos ; Ferreira, Natália Soares; Maeda, Denicar Lina Nascimento Fabris; Sales, Natiely Silva; Rosa, Daniela Santoro; Ferreira, Luís Carlos de Souza ; Boscardin, Silvia Beatriz
Fonte: Frontiers in Immunology. Unidade: ICB
Assuntos: PARASITOLOGIA, MICROBIOLOGIA, CÉLULAS DENDRÍTICAS, VACINAS VIRAIS, DNA VIRAL, DENGUE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ZANETI, Arthur Baruel et al. Dendritic cell targeting using a DNA vaccine induces specific antibodies and CD4+ T cells to the dengue virus envelope protein Domain III. Frontiers in Immunology, v. 10, p. 1-15, 2019Tradução . . Disponível em: https://doi.org/10.3389/fimmu.2019.00059. Acesso em: 19 nov. 2024.
APA
Zaneti, A. B., Yamamoto, M. M., Sulczewski, F. B., Almeida, B. da S., Souza, H. F. S., Ferreira, N. S., et al. (2019). Dendritic cell targeting using a DNA vaccine induces specific antibodies and CD4+ T cells to the dengue virus envelope protein Domain III. Frontiers in Immunology, 10, 1-15. doi:10.3389/fimmu.2019.00059
NLM
Zaneti AB, Yamamoto MM, Sulczewski FB, Almeida B da S, Souza HFS, Ferreira NS, Maeda DLNF, Sales NS, Rosa DS, Ferreira LC de S, Boscardin SB. Dendritic cell targeting using a DNA vaccine induces specific antibodies and CD4+ T cells to the dengue virus envelope protein Domain III [Internet]. Frontiers in Immunology. 2019 ; 10 1-15.[citado 2024 nov. 19 ] Available from: https://doi.org/10.3389/fimmu.2019.00059
Vancouver
Zaneti AB, Yamamoto MM, Sulczewski FB, Almeida B da S, Souza HFS, Ferreira NS, Maeda DLNF, Sales NS, Rosa DS, Ferreira LC de S, Boscardin SB. Dendritic cell targeting using a DNA vaccine induces specific antibodies and CD4+ T cells to the dengue virus envelope protein Domain III [Internet]. Frontiers in Immunology. 2019 ; 10 1-15.[citado 2024 nov. 19 ] Available from: https://doi.org/10.3389/fimmu.2019.00059

Unidades USP

ReP

Filtros

Autores

Autores USP

Assuntos

Agência de fomento

Afiliação dos autores externos não normalizada